PHASE ONE’s 25th Anniversary Gala Breaks Records– Raising Over $1.2M for Clinical Cancer Research Madelyn OlsenMay 20, 2024Events, Foundation News
Promising New Combination Therapy May Pave the Way for Targeted Treatment in Non-Hodgkin Lymphoma Madelyn OlsenApril 17, 2024Grant Announcement
Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope Madelyn OlsenDecember 12, 2023Grant Announcement
PHASE ONE Foundation Welcomes Three New Board Members: Rebecca Cocco, Paula Selesnick, and Cindy Ruby Madelyn OlsenSeptember 22, 2023Foundation News
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors Madelyn OlsenSeptember 19, 2023Grant Announcement
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments Madelyn OlsenJuly 27, 2023Grant Announcement
PHASE ONE’s 2023 Annual Gala Raises Over $1M for Clinical Cancer Research Madelyn OlsenMay 4, 2023Events, Foundation News
PHASE ONE Funds Imerman Angels’ Clinical Trial Matching Program Madelyn OlsenApril 6, 2023Grant Announcement
